;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Auris Medical amends IPO

    Auris Medical Holding AG, Zug, Switzerland Business: Other Date announced: 2014-07-21 Type: IPO To be raised: Up to $82.8 million Shares: 6.9 million Price: $10-$12 Underwriters: Jefferies; Leerink Partners; JMP …

    Published on 7/28/2014
  • Avalanche Biotechnologies amends IPO

    Avalanche Biotechnologies Inc., Menlo Park, Calif. Business: Ophthalmic Date announced: 2014-07-21 Type: IPO To be raised: Up to $81 million Shares: 5.4 million Price: $13-$15 Underwriters: Jefferies; Cowen; Piper …

    Published on 7/28/2014
  • ContraFect amends IPO

    ContraFect Corp., Yonkers, N.Y. Business: Infectious, Antibodies Date announced: 2014-07-24 Type: IPO To be raised: Up to $32.7 million Units: 5.5 million Price: $5-$6 (unit) Underwriter: Maxim Group Overallotment: 818,…

    Published on 7/28/2014
  • Lantheus Holdings amends IPO

    Lantheus Holdings Inc., North Billerica, Mass. Business: Diagnostic Date announced: 2014-07-24 Type: IPO To be raised: Up to $138.9 million Shares: 9.3 million Price: $12-$15 Underwriters: Citigroup; Jefferies; RBC …

    Published on 7/28/2014
  • Loxo amends IPO

    Loxo Oncology Inc., Stamford, Conn. Business: Cancer Date announced: 2014-07-21 Type: IPO To be raised: Up to $61.4 million Shares: 4.4 million Price: $12-$14 Underwriters: Cowen; Stifel, Nicolaus; Oppenheimer; JMP …

    Published on 7/28/2014
  • Tobira amends IPO

    Tobira Therapeutics Inc., San Francisco, Calif. Business: Infectious Date announced: 2014-07-21 Type: IPO To be raised: Up to $64.6 million Shares: 4.6 million Price: $12-$14 Underwriters: BMO Capital Markets; JMP …

    Published on 7/28/2014
  • Applied Genetic Technologies completes follow-on

    Applied Genetic Technologies Corp. (NASDAQ:AGTC), Alachua, Fla. Business: Gene/Cell therapy Date completed: 2014-07-24 Type: Follow-on Raised: $30 million Shares: 2 million Price: $15 Shares after offering: 16.1 million…

    Published on 7/28/2014
  • Atox Bio completes venture financing

    Atox Bio Inc., Ness Ziona, Israel Business: Infectious, Autoimmune Date completed: 2014-07-24 Type: Venture financing Raised: Not disclosed Investors: SR One; Lundbeckfond Ventures; OrbiMed Advisors Note: Atox raised an…

    Published on 7/28/2014
  • Augmenix completes venture financing

    Augmenix Inc., Waltham, Mass. Business: Supply/Service Date completed: 2014-07-23 Type: Venture financing Raised: $10.8 million Investors: CHV II; Excelestar Ventures; Catalyst Health Ventures; Sparta Group; individual …

    Published on 7/28/2014
  • BioAlliance completes debt financing

    BioAlliance Pharma S.A. (Euronext:BIO), Paris, France Business: Cancer, Infectious, Drug delivery Date completed: 2014-07-18 Type: Debt financing Raised: EUR10 million ($13.5 million) Investor: Financire de la Montagne …

    Published on 7/28/2014
  • CareDx completes IPO

    CareDx Inc. (NASDAQ:CDNA), Brisbane, Calif. Business: Diagnostic Date completed: 2014-07-17 Type: IPO Raised: $40 million Shares: 4 million Price: $10 Shares after offering: 11.6 million Underwriters: Piper Jaffray; …

    Published on 7/28/2014
  • Cerecor completes venture financing

    Cerecor Inc., Baltimore, Md. Business: Neurology, Pulmonary Date completed: 2014-07-21 Type: Venture financing Raised: $15 million Investors: New Enterprise Associates; Apple Tree Partners; MPM Capital Note: The company…

    Published on 7/28/2014
  • CymaBay completes follow-on

    CymaBay Therapeutics Inc. (NASDAQ:CBAY), Newark, Calif. Business: Endocrine/Metabolic Date completed: 2014-07-22 Type: Follow-on Raised: $22 million Shares: 4 million Price: $5.50 Shares after offering: 14.1 million …

    Published on 7/28/2014
  • DesignMedix completes venture financing

    DesignMedix Inc., Portland, Ore. Business: Infectious Date completed: 2014-07-17 Type: Venture financing Raised: $1.5 million Investors: Portland Seed Fund; Bellingham Angels; Oregon Angel Fund; Seraph Angel Network; …

    Published on 7/28/2014
  • GeneCentric Diagnostics completes venture financing

    GeneCentric Diagnostics Inc., Durham, N.C. Business: Diagnostic Date completed: 2014-07-11 Type: Venture financing Raised: $5 million Note: The company raised $5 million, according to an SEC filing.

    Published on 7/28/2014
  • Immune Design completes IPO

    Immune Design Corp. (NASDAQ:IMDZ), Seattle, Wash. Business: Infectious, Cancer Date completed: 2014-07-24 Type: IPO Raised: $60 million Shares: 5 million Price: $12 Shares after offering: 15.1 million Underwriters: …

    Published on 7/28/2014
  • Innocoll completes IPO

    Innocoll GmbH (NASDAQ:INNL), Athlone, Ireland Business: Drug delivery, Neurology, Infectious Date completed: 2014-07-25 Type: IPO Raised: $58.5 million Shares: 6.5 million Price: $9 Shares after offering: 19.8 million …

    Published on 7/28/2014
  • Intersect completes IPO

    Intersect ENT Inc. (NASDAQ:XENT), Palo Alto, Calif. Business: Infectious Date completed: 2014-07-24 Type: IPO Raised: $55 million Shares: 5 million Price: $11 Shares after offering: 22.5 million Underwriters: JPMorgan; …

    Published on 7/28/2014
  • La Jolla Pharmaceutical completes follow-on

    La Jolla Pharmaceutical Co. (NASDAQ:LJPC), San Diego, Calif. Business: Autoimmune Date completed: 2014-07-23 Type: Follow-on Raised: $50.4 million Shares: 4.8 million Price: $10.50 Shares after offering: 12.1 million …

    Published on 7/28/2014
  • Mela Sciences completes private placement of convertible preferred stock

    Mela Sciences Inc. (NASDAQ:MELA), Irvington, N.Y. Business: Diagnostic Date completed: 2014-07-24 Type: Private placement of convertible preferred stock Raised: $27.3 million Shares: 12,300 Price: $1,000 Shares …

    Published on 7/28/2014
  • NexImmune completes venture financing

    NexImmune Inc., Gaithersburg, Md. Business: Cancer Date completed: 2014-07-17 Type: Venture financing Raised: $3 million Investors: New Enterprise Associates; Pfizer Venture Investments; Amgen Ventures

    Published on 7/28/2014
  • Ocular Therapeutix completes IPO

    Ocular Therapeutix Inc. (NASDAQ:OCUL), Bedford, Mass. Business: Ophthalmic Date completed: 2014-07-24 Type: IPO Raised: $65 million Shares: 5 million Price: $13 Shares after offering: 20.6 million Underwriters: Morgan …

    Published on 7/28/2014
  • Orthocell completes IPO

    Orthocell Ltd. (ASX:OCC), Murdoch, Australia Business: Transplant Date completed: 2014-07-22 Type: IPO Raised: A$8 million ($7.5 million) Shares: 20 million Price: A$0.40 Shares after offering: 82.5 million Note: The …

    Published on 7/28/2014
  • Pfenex completes IPO

    Pfenex Inc. (NASDAQ:PFNX), San Diego, Calif. Business: Biosimilars, Supply/Service Date completed: 2014-07-24 Type: IPO Raised: $50 million Shares: 8.3 million Price: $6 Shares after offering: 19.2 million Underwriters:…

    Published on 7/28/2014
  • Roka completes IPO

    Roka Bioscience Inc. (NASDAQ:ROKA), Warren, N.J. Business: Diagnostic Date completed: 2014-07-17 Type: IPO Raised: $60 million Shares: 5 million Price: $12 Shares after offering: 17.6 million Underwriters: BofA Merrill …

    Published on 7/28/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993